Despite the strong export performance, the overall Q3 results were seen as somewhat lacklustre, leading to mixed reactions ...
OneSource Specialty Pharma has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for its BLD facility in ...